Prophylaxis of radiotherapy-induced nausea and vomiting in the palliative treatment of bone metastases

Supportive Care in Cancer

Volumn 20, Issue 8, 2012, Pages 1673-1678

  Dennis, Kristopher ^a   Nguyen, Janet ^a   Presutti, Roseanna ^a   DeAngelis, Carlo ^a   Tsao, May ^a   Danjoux, Cyril ^a   Barnes, Elizabeth ^a   Sahgal, Arjun ^a   Holden, Lori ^a   Jon, Florencia ^a   Wong, Shun ^a   Chow, Edward ^a  

^a DEPARTMENT OF RADIATION ONCOLOGY   (Canada)

Author keywords

Bone metastases; Emesis; Nausea; Palliative care; Radiotherapy; Vomiting

Indexed keywords

ONDANSETRON; SEROTONIN 3 ANTAGONIST;

ADULT; ARTICLE; BONE METASTASIS; CANCER INCIDENCE; CANCER RISK; DISEASE SEVERITY; FEMALE; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; NAUSEA AND VOMITING; PALLIATIVE THERAPY; PRESCRIPTION; PRIORITY JOURNAL; PROSTATE CANCER; RADIATION DOSE; RADIATION INJURY; RADIOTHERAPY INDUCED NAUSEA VOMITING; TREATMENT DURATION;

ADULT; AGED; AGED, 80 AND OVER; ANTIEMETICS; BONE NEOPLASMS; FEMALE; HUMANS; MALE; MIDDLE AGED; NAUSEA; ONDANSETRON; PALLIATIVE CARE; TREATMENT OUTCOME; VOMITING;

EID: 84863984333     PISSN: 09414355     EISSN: 14337339     Source Type: Journal    
DOI: 10.1007/s00520-011-1258-x     Document Type: Article

References (15)

1. Feyer PCh, Maranzano E, Molassiotis A, Clark-Snow RA, Roila F, Warr D, Olver I (2005) Radiotherapy-induced nausea and vomiting (RINV): antiemetic guidelines. Support Care Cancer 13 (2):122-128
2. Feyer PC, Maranzano E, Molassiotis A, Roila F, Clark-Snow RA, Jordan K (2011) Radiotherapy-induced nausea and vomiting (RINV): MASCC/ESMO guideline for antiemetics in radiotherapy: update 2009. Support Care Cancer 19(Suppl 1):S5-S14
3. Maranzano E, DeAngelis V, Pergolizzi S, Lupattelli M, Frata P, Spagnesi S, Frisio ML, Mandoliti G, Malinverni G, Trippa F, Fabbietti L, Parisi S, Di Palma A, De Vecchi P, De Renzis C, Giorgetti C, Bergami T, Orecchia R, Portaluri M, Signor M, Di Gennaro D (2010) Italian Group for Antiemetic Research in Radiotherapy-IGARR. A prospective observational trial on emesis in radiotherapy: analysis of 1020 patients recruited in 45 Italian radiation oncology centres. Radiother Oncol 94(1):36-41
4. Enblom A, Bergius AB, Steineck G, Hammar M, Borjeson S (2009) One third of patients with radiotherapy-induced nausea consider their antiemetic treatment insufficient. Support Care Cancer 17(1):23-32
5. Horiot JC (2004) Prophylaxis versus treatment: is there a better way to manage radiotherapy-induced nausea and vomiting? Int J Radiat Oncol Biol Phys 60(4):1018-1025
6. Kris MG, Hesketh PJ, Somerfield MR, Feyer P, Clark-Snow R, Koeller JM, Morrow GR, Chinnery LW, Chesney MJ, Fralla RJ, Grunberg SM (2006) American Society of Clinical Oncology guideline for antiemetics in oncology: update 2006. J Clin Oncol 24(18):2932-2947
7. National Comprehensive Cancer Network. Clinical practice guidelines in oncology. Antiemesis. V.3.2011. Available at http://www.nccn.org/clinical.asp
8. Salvo N, Doble B, Khan L, Amirthevasar G, Dennis K, Pasetka M, Deangelis C, Tsao M, Chow E (2010) Prophylaxis of radiationinduced nausea and vomiting using 5-hydroxytryptamine-3 serotonin receptor antagonists: a systematic review of randomized trials. Int J Radiat Oncol Biol Phys. doi:10.1016/j.ijrobp.2010. 08.060
9. Presutti R, Nguyen J, Holden L, Deangelis C, Culleton S, Mitera G, Tsao M, Barnes EA, Danjoux C, Sahgal A, Salvo N, Khan L, Chow E (2011) Radiation-induced nausea and vomiting in a palliative radiotherapy clinic: a preliminary analysis. J Pain Manag 3(3):301-307
10. Priestman TJ, Roberts JT, Lucraft H, Collis CH, Adams M, Upadhyaya BK, Priestman S (1990) Results of a randomized, double-blind comparative study of ondansetron and metoclopramide in the prevention of nausea and vomiting following highdose upper abdominal irradiation. Clin Oncol (R Coll Radiol) 2:71-75
11. Bey P, Wilkinson PM, Resbeut M, Bourdin S, Le Floch O, Hahne W, Claverie N (1996) A double-blind, placebocontrolled trial of i.v. dolasetron mesilate in the prevention of radiotherapy-induced nausea and vomiting in cancer patients. Support Care Cancer 4:378-383
12. Priestman TJ, Roberts JT, Upadhyaya BK (1993) A prospective randomized double-blind trial comparing ondansetron versus prochlorperazine for the prevention of nausea and vomiting in patients undergoing fractionated radiotherapy. Clin Oncol (R Coll Radiol) 5:358-363
13. Sykes AJ, Kiltie AE, Stewart AL (1997) Ondansetron versus a chlorpromazine and dexamethasone combination for the prevention of nausea and vomiting: a prospective, randomized study to assess efficacy, cost effectiveness and quality of life following single-fraction radiotherapy. Support Care Cancer 5:500-503
14. Mystakidou K, Katsouda E, Linou A, Parpa E, Kouloulias V, Nikolaou V, Vlahos L (2006) Prophylactic tropisetron versus rescue tropisetron in fractionated radiotherapy to moderate or high emetogenic areas. Med Oncol 23(3):251-262
15. Wong RKS, Paul N, Ding K, Whitehead M, Brundage M, Fyles A, Wilke D, Nabid A, Fortin A, Wilson D, McKenzie M, Ackerman I, Souhami L, Chabot P, Pater J (2006) 5-hydroxytryptamin-3 receptor antagonist with or without shortcourse dexamethasone in the prophylaxis of radiation induced emesis: a placebo-controlled randomized trial of the National Cancer Institute of Canada Clinical Trials Group (SC19). J Clin Oncol 24(21):3458-3464